BlackRock Institutional Trust’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$12.3M	Buy	5,819,729 +718,707	+14%	+$2.01M	﹤0.01%	2286
2016 Q3	$17.1M	Sell	5,101,022 -72,002	-1%	-$229K	﹤0.01%	1996
2016 Q2	$16.2M	Buy	5,173,024 +250,137	+5%	+$834K	﹤0.01%	1981
2016 Q1	$16.4M	Buy	4,922,887 +238,586	+5%	+$744K	﹤0.01%	1947
2015 Q4	$16.6M	Buy	4,684,301 +109,337	+2%	+$458K	﹤0.01%	1989
2015 Q3	$23M	Sell	4,574,964 -40,578	-0.9%	-$233K	﹤0.01%	1742
2015 Q2	$29.7M	Sell	4,615,542 -45,884	-1%	-$307K	﹤0.01%	1639
2015 Q1	$32.8M	Buy	4,661,426 +100,109	+2%	+$725K	0.01%	1599
2014 Q4	$35.2M	Sell	4,561,317 -3,507	-0.1%	-$27.8K	0.01%	1529
2014 Q3	$34.1M	Sell	4,564,824 -47,359	-1%	-$440K	0.01%	1524
2014 Q2	$44.6M	Sell	4,612,183 -40,926	-0.9%	-$365K	0.01%	1390
2014 Q1	$38.7M	Buy	4,653,109 +269,073	+6%	+$2.31M	0.01%	1480
2013 Q4	$37M	Buy	4,384,036 +15,215	+0.3%	+$128K	0.01%	1487
2013 Q3	$34.8M	Sell	4,368,821 -87,039	-2%	-$700K	0.01%	1444
2013 Q2	$34.4M	Buy	+4,455,860	New	+$34.7M	0.01%	1403